Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Revenue
Operating expenses:
General and administrative (including stock-based compensation (Note 8))	526,697	550,095	951,388	1,058,000
Depreciation	503	76,083	1,005	151,962
Research and development (including stock-based compensation (Note 8))	126,082	84,286	238,325	218,775
Total operating expenses	653,282	710,464	1,190,718	1,428,737
Loss from operations	(653,282)	(710,464)	(1,190,718)	(1,428,737)
Other expense:
Interest expense, net	94,565	86,905	187,329	201,661
Total other expense	94,565	86,905	187,329	201,661
Net loss	(747,847)	(797,369)	(1,378,047)	(1,630,398)
Net loss attributable to the noncontrolling interest	862	1,274	1,396	2,569
Net loss applicable to Bion's common stockholders	$ (746,985)	$ (796,095)	$ (1,376,651)	$ (1,627,829)
Net loss applicable to Bion's common stockholders per basic and diluted common share (in dollars per share)	$ (0.03)	$ (0.03)	$ (0.06)	$ (0.07)
Basic and diluted (in shares)	23,328,499	22,585,001	23,436,311	22,437,039